U.S. Dupixent Market (2025 - 2033) Size, Share & Trends Analysis Report By Indication (Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyps, Chronic Obstructive Pulmonary Disease, Bullous Pemphigoid), By Distribution Channel, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Indication
                        1.2.2. Distribution Channel
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Dupixent Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Patent Expiry Analysis
                        3.3.5. Pricing Analysis
Chapter 4. U.S. Dupixent Market: Indication Business Analysis
                    4.1. Indication Market Share, 2024 & 2033
                    4.2. Indication Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Billion)
                    4.4. Atopic Dermatitis (AD)
                        4.4.1. Atopic Dermatitis (AD) Market, 2021 - 2033 (USD Billion)
                    4.5. Asthma
                        4.5.1. Asthma Market, 2021 - 2033 (USD Billion)
                    4.6. Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
                        4.6.1. Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Market, 2021 - 2033 (USD Billion)
                    4.7. Chronic Obstructive Pulmonary Disease (COPD)
                        4.7.1. Chronic Obstructive Pulmonary Disease (COPD) Market, 2021 - 2033 (USD Billion)
                    4.8. Others
                        4.8.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 5. U.S. Dupixent Market: Distribution Channel Business Analysis
                    5.1. Distribution Channel Market Share, 2024 & 2033
                    5.2. Distribution Channel Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
                    5.4. Hospital Pharmacies
                        5.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
                    5.5. Retail Pharmacies
                        5.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
                    5.6. Others
                        5.6.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 6. Competitive Landscape
                    6.1. Participant Overview
                    6.2. Company Market Position Analysis
                    6.3. Company Categorization
                    6.4. Strategy Mapping
                    6.5. Company Profiles/Listing
                        6.5.1. Sanofi
                            6.5.1.1. Overview
                            6.5.1.2. Financial Performance
                            6.5.1.3. Product Benchmarking
                            6.5.1.4. Strategic Initiatives
                        6.5.2. Regeneron
                            6.5.2.1. Overview
                            6.5.2.2. Financial Performance
                            6.5.2.3. Product Benchmarking
                            6.5.2.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. Dupixent market, by region, 2021 - 2033 (USD Billion)
Table 4 U.S. Dupixent market, by indication, 2021 - 2033 (USD Billion)
Table 5 U.S. Dupixent market, by distribution channel, 2021 - 2033 (USD Billion)

List of Figures

Fig. 1 U.S. Dupixent market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and application outlook (USD Billion)
Fig. 10 Competitive landscape
Fig. 11 Dupixent market dynamics
Fig. 12 Dupixent market: Porter’s five forces analysis
Fig. 13 Dupixent market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Billion)
Fig. 15 Atopic Dermatitis (AD) market, 2021 - 2033 (USD Billion)
Fig. 16 Asthma market, 2021 - 2033 (USD Billion)
Fig. 17 Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) market, 2021 - 2033 (USD Billion)
Fig. 18 Chronic Obstructive Pulmonary Disease (COPD) market, 2021 - 2033 (USD Billion)
Fig. 19 Others market, 2021 - 2033 (USD Billion)
Fig. 20 Distribution Channel market, 2021 - 2033 (USD Billion)
Fig. 21 Hospital Pharmacies market, 2021 - 2033 (USD Billion)
Fig. 22 Retail Pharmacies market, 2021 - 2033 (USD Billion)
Fig. 23 Others market, 2021 - 2033 (USD Billion)
Fig. 24 Company categorization
Fig. 25 Company market position analysis
Fig. 26 Strategic framework